Yes, Wegovy and metformin are sometimes used together, particularly in women with insulin resistance
Results so far have shown a pharmacokinetic profile supportive of once-daily dosing, with a safety profile consistent with previous danuglipron studies, including no liver enzyme elevations in over 1,400 study participants
Whether GLP-1 medications directly improve lymphatic vessel performance remains an active area of investigation
Its also useful context for understanding why weight loss may have been difficult before treatment and why semaglutides insulin-sensitizing effects are particularly relevant for their situation
Many prefer this peptide for its ability to boost muscle growth and increase lean body mass
Heres why AND what to do: Rapid weight loss from GLP-1s can trigger telogen effluvium, a common form of temporary hair shedding